Premium
S3‐04–06: Deletion of IRS2 reduces amyloid deposition, inhibits GSK‐3 and rescues behavioral deficits in APP transgenic mice
Author(s) -
Lovestone Simon
Publication year - 2008
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2008.05.397
Subject(s) - irs2 , insulin degrading enzyme , insulin resistance , endocrinology , medicine , insulin receptor , genetically modified mouse , insulin receptor substrate , insulin , gsk 3 , glycogen synthase , phosphorylation , transgene , irs1 , kinase , biology , chemistry , microbiology and biotechnology , biochemistry , gene
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom